Stock Research: Fresenius Medical Care

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Fresenius Medical Care

XTRA:FME DE0005785802
63
  • Value
    59
  • Growth
    32
  • Safety
    Safety
    95
  • Combined
    78
  • Sentiment
    33
  • 360° View
    360° View
    63
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Fresenius Medical Care AG is a Germany-based kidney dialysis institute providing dialysis care and related services for end-stage renal disease (ESRD) and other extracorporeal therapies. It operates in healthcare services, including R&D, manufacturing, supply chain, and commercial operations, developing both dialysis and non-dialysis products. In the last fiscal year, the company had a market cap of $15757 million, profits of $4925 million, revenue of $20019 million, and 111513 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 63 (better than 63% compared with alternatives), overall professional sentiment and financial characteristics for the stock Fresenius Medical Care are above average. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for Fresenius Medical Care. The consolidated Value Rank has an attractive rank of 95, which means that the share price of Fresenius Medical Care is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 95% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 59. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 33. Professional investors are more confident in 67% other stocks. The consolidated Growth Rank also has a low rank of 32, which means that the company is below average in terms of growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. 68 of its competitors have better growth. ...read more

more
Index
CDAX
DAX 40
Dividends Europe
Human Rights
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 4-Sep-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
95 88 83 89
Growth
32 38 31 27
Safety
Safety
59 61 74 41
Sentiment
33 58 23 9
360° View
360° View
63 81 54 31
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
19 13 8 21
Opinions Change
38 65 53 29
Pro Holdings
n/a 51 24 46
Market Pulse
78 81 64 34
Sentiment
33 58 23 9
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
95 88 83 89
Growth
32 38 31 27
Safety Safety
59 61 74 41
Combined
78 83 82 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
89 77 77 89
Price vs. Earnings (P/E)
75 69 72 75
Price vs. Book (P/B)
86 82 84 84
Dividend Yield
88 77 74 84
Value
95 88 83 89
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
10 29 10 32
Profit Growth
74 39 8 6
Capital Growth
29 42 82 84
Stock Returns
73 82 83 27
Growth
32 38 31 27
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
36 31 38 24
Refinancing
79 77 77 47
Liquidity
34 42 42 39
Safety Safety
59 61 74 41

Similar Stocks

Discover high‑ranked alternatives to Fresenius Medical Care and broaden your portfolio horizons.

Hornbach Holding

XTRA:HBH
Country: Germany
Industry: Home Improvement Retail
Size: Large
Full Stock Analysis

KSB

XTRA:KSB
Country: Germany
Industry: Industrial Machinery
Size: Medium
Full Stock Analysis

thyssenkrupp

XTRA:TKA
Country: Germany
Industry: Steel
Size: X-Large
Full Stock Analysis

Drägerwerk

XTRA:DRW3
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.